The DOI matches its Crossref record.
Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage
Abstract
PURPOSE: While radical cystectomy remains the treatment of choice for invasive transitional cell carcinoma, the importance of its timing has been increasingly scrutinized. We determined whether the interval between diagnosis of muscle invasion and definitive radical cystectomy influenced pathological staging outcome. MATERIALS AND METHODS: Of the 303 patients who underwent radical cystectomy from January 1998 to December 2001, 153 were diagnosed with muscle invasive transitional cell carcinoma at transurethral resection. Charts were reviewed for pathological stage, demographics and time between diagnosis of muscle invasion and radical cystectomy. RESULTS: Mean patient age was 67.2 years (range 35 to 88) with the majority (121 of 153, 79%) being male. At the time of cystectomy, 68 of 153 (44%) patients had organ confined disease (pT2B or lower), while node positive disease was found in 58 of 153 patients (38%). Mean time from transurethral resection diagnosis of muscle invasive disease until cystectomy was 63 days (range 8 to 473). A statistically significant correlation existed between time of diagnosis and cystectomy, and final pathological stage. Specifically, those patients with an interval greater than 90 days were more likely to have pT3 or higher, nonorgan confined disease compared to those patients undergoing cystectomy before 90 days (81% versus 52%, p = 0.01). Furthermore, those patients with organ confined disease had a significantly shorter mean time between diagnosis and cystectomy of 47.5 days versus 75.1 days for nonorgan confined disease (t test p = 0.02). CONCLUSIONS: In patients with muscle invasion at diagnosis, a delay in surgery is associated with more advanced pathological stage, especially when the delay is longer than 90 days. While appropriate time should be given for consideration of options and pretreatment evaluation, undue delay may compromise cancer control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
Witjes, J. A., Compérat, E., Cowan, N. C., De Santis, M., Gakis, G., Lebret, T., Ribal, M. J., Van der Heijden, A. G., & Sherif, A. (2014) · European Urology · doi:10.1016/j.eururo.2013.11.046 · Cited by 1,002
Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay
Grossman, H. B. (2006) · JAMA · doi:10.1001/jama.295.3.299 · Cited by 265
Longer Wait Times Increase Overall Mortality in Patients With Bladder Cancer
Kulkarni, G. S., Urbach, D. R., Austin, P. C., Fleshner, N. E., & Laupacis, A. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.06.041 · Cited by 123
Metadata
- Authors
- CHANG, S. S., HASSAN, J. M., COOKSON, M. S., WELLS, N., & SMITH, J. A.
- Venue
- Journal of Urology
- Published
- 2003-10
- Volume
- 170
- Issue
- 4 Part 1
- Pages
- 1085-1087
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2083847009
- Cited by
- 179
- References
- 0
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage. https://app.cochat.ai/papers/10.1097/01.ju.0000086828.26001.ca
- The paper
- CHANG, S. S., HASSAN, J. M., COOKSON, M. S., WELLS, N., & SMITH, J. A. (2003). Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage. Journal of Urology. https://doi.org/10.1097/01.ju.0000086828.26001.ca
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.